BioCityPharma - Crunchbase Company Profile & Funding

Q: Where is BioCityPharma's headquarters?

BioCityPharma is located in Shanghai, Shanghai, China.

Q: Who invested in BioCityPharma?

BioCityPharma has 2 investors including Wuxi Venture Capital Group And Binhu Industry Group.

Q: When was the last funding round for BioCityPharma?

BioCityPharma closed its last funding round on obfuscated from a Series A round.

Overview

BioCityPharma

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About BioCityPharma

CB Rank

681671

BioCityPharma is a clinical-stage biopharmaceutical firm.

Founded

obfuscation

Private

Series A

Shanghai, Shanghai, China

51-100

www.biocitypharma.com

Funding Rounds

Series A

OBF

obfuscation

Key People

Ivy Wang: Co-Founder, EVP, and CSO
Yongjiang Hei: CEO

Details

Also Known As

智康弘义, Zhikang Hongyi

Operating Status

Active

Company Type

For Profit

Founders

Ivy Wang, Xiang Jia

About the Company

BioCityPharma is a clinical-stage biopharmaceutical firm focused on discovering innovative, highly differentiated, modality-independent treatment options for cancer and nephropathy.

Phone Number

0510-88856588

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Runway Speculation

Products & Services

SC0062

An oral endothelin A receptor selective antagonist for treating chronic kidney disease by reducing proteinuria and improving renal function.

BC3195 (CDH3 ADC)

An antibody-drug conjugate targeting CDH3 for treatment of advanced solid tumors by delivering cytotoxic agents to cancer cells.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A
obfuscated obfuscation	Series A - BioCityPharma	2	obfuscated obfuscation	Binhu Industry Group, Wuxi Venture Capital Group	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wuxi Venture Capital Group	Yes	Series A - BioCityPharma	—
Wuxi Venture Capital Group	Yes	Series A - BioCityPharma	—
Wuxi Venture Capital Group	Yes	Series A - BioCityPharma	—
Wuxi Venture Capital Group	Yes	Series A - BioCityPharma	—
Wuxi Venture Capital Group	Yes	Series A - BioCityPharma	—